Last update 31 Jan 2026

MG-O-1002

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
MG O 1002, MG-O-1002, TO-O-1002
+ [1]
Target
VEGF
Action
inhibitors
Mechanism
VEGF inhibitors(Vascular endothelial growth factor inhibitors)
Therapeutic Areas
Congenital DisordersEye DiseasesCardiovascular Diseases+ [1]
Active Indication
Age Related Macular DegenerationWet age-related macular degenerationDiabetic macular oedema
Inactive Indication-
Originator Organization
Metagone Biotech, Inc.
Active Organization
Metagone Biotech, Inc.Theratocular Biotek Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with MG-O-1002
NCT05390840
/ Unknown statusPhase 2
A Phase II Trial to Evaluate the Efficacy and Safety of Topical Ocular MG-O-1002 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
100 Clinical Results associated with MG-O-1002
Login to view more data
100 Translational Medicine associated with MG-O-1002
Login to view more data
100 Patents (Medical) associated with MG-O-1002
Login to view more data
100 Deals associated with MG-O-1002
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Age Related Macular DegenerationPhase 2
Thailand
Metagone Biotech, Inc.
09 Aug 2022
Wet age-related macular degenerationPhase 2
Thailand
Theratocular Biotek Co., Ltd.
09 Aug 2022
Diabetic macular oedemaIND Application
Taiwan Province
Metagone Biotech, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free